DRKS00023575已完成不适用
Infections in hospitalized patients with rheumatic diseases between 2000 and 2020 - /
niversitätsklinikum Halle (Saale) Klinik für Innere Medizin II0 个研究点目标入组 78 人开始时间: 2021年4月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Adult patients (from the age of 18). Inpatient admission to Halle University Hospital in the period from 01.01.2000 to 31.12.2020. Inpatient admission to the Department of Internal Medicine (DIM) due to a serious infection (ICD code see above) defined as a potentially life-threatening infection with the need for antibiotic therapy and inpatient admission. In addition, a confirmed diagnosis of the above rheumatic diseases or above degenerative diseases.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Investigation of incidence of infections in patients with IBDlcerative colitis, Crohn's disease, Indeterminate colitisJPRN-UMIN000005445Gastroenterology and Hepatology, Tokyo Medical and Dental University200
进行中（未招募）
不适用
Nosocomial Infections in ECMO PatientsNosocomial InfectionExtracorporeal Membrane Oxygenation ComplicationAcute Respiratory Distress SyndromeNCT05566665Policlinico Hospital200
招募中
不适用
Incidence of parasitic infection in patients with hypereosinophiliaThe patient 18 years and older who were diagnosed with more eosinophils 1,500/cu.mm.Incidence of parasitic infection in patients with hypereosinophilia. The patient 18 years and older who were diagnosed with more eosinophils 1,500/cu.mm.TCTR20211129002Siriraj Hospital Mahidol University120
尚未招募
不适用
A backdated comparison of patients operated before the COVID-19 pandemic versus those operated during the COVID_19 pandemic.CTRI/2020/08/027210Tata Memorial Centre
进行中（未招募）
不适用
Antibiotic treatment in patients hospitalized with an acute exacerbation in chronic obstructive pulmonary disease. Effect of one day of antibiotic treatment compared t0 6 days of antibiotic treatment in patients who are clinically stable 24 hours after hospitalization. A prospective, randomized, double-blind trial - TaexaCOPAcute exacerbation of chronic ostructive pulmonary disease in hospitalized patients. All patients receive standard of care, and 1 day of intravenous antibiotics. In addition patients are randomized to treatment with Vibradox 200 mg QD in 5 days or matching placebo. The primary outcome variable is 6 minutes walking distance at day 14 after hospitalization.MedDRA version: 9.1Level: LLTClassification code 10056971Term: Infective exacerbation of chronic obstructive airways diseaseEUCTR2007-007275-16-DKDepartment of Infetious Diseases, Odense University Hospital